News | Radiation Therapy | October 29, 2018

RaySearch Demonstrates New Machine Learning Applications at ASTRO

Company showcases latest developments for treatment planning and oncology information systems

RaySearch Demonstrates New Machine Learning Applications at ASTRO

October 29, 2018 — RaySearch exhibited its latest advances in oncology software at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting, Oct. 21-24 in San Antonio, Texas, backed by machine learning and user-friendly tools to enable optimal use of clinical resources. The company showed its latest development in machine learning technology and automation in both its RayStation treatment planning system (TPS) and RayCare oncology information system (OIS).

With its in-house machine learning department, RaySearch is currently developing machine learning and deep learning prototypes for areas such as treatment plan generation, organ segmentation and target volume estimation. RaySearch is also developing techniques for efficient large-scale data extraction and analysis. The first clinical applications of machine learning are automated treatment planning and automated organ segmentation and will be included in the next RayStation release in December.

The RayCare next-generation OIS is now directly connected to the treatment delivery system at the Provision Cares Proton Therapy facility in Nashville. RayCare is used to manage the radiation therapy treatment sessions. The Nashville center treated their first patient on Oct. 8 and utilizes the RayCare OIS together with the RayStation TPS to plan and manage its proton treatments.

RayCare 2B was released early October and was displayed at the show. This version introduces new features and usability improvements throughout the system, including a feature to support a full treatment delivery and management workflow and task-based offline image review. Other care administration features include support for financial information, such as insurance information and authorization management, and support for managing external contacts, referring clinicians and other external entities.

RaySearch also offered joint product demonstrations with other ASTRO 2018 exhibitors, including:

  • IBA and RaySearch presented their online adaptive proton therapy workflow, where daily optimized plans are created for the individual patient based on cone beam computed tomography (CBCT) images to preserve the original treatment intent. Both companies offered demonstrations including RayCare, RayStation, the AdaPT Insight imaging platform and the AdaPT Deliver treatment delivery. The solution can automatically suggest to the care team an adapted treatment plan that considers the most up-to-date patient anatomy. This workflow offers more accurate treatment plans as well as faster plan adaptation to the benefit of patients;
  • In the Accuray booth, presentations of RayStation and RayCare for the TomoTherapy platform were available. RayStation 8A, released earlier this summer, includes full support for the TomoTherapy and Radixact Systems. All TomoTherapy and Radixact users can now get access to advanced RayStation features, including multi-criteria optimization (MCO), adaptive planning and Plan Explorer; and
  • Mevion Medical Systems showed the latest proton therapy news with the Mevion S250i system with Hyperscan Pencil Beam Scanning demonstrations, using RayStation.

For more information: www.raysearchlabs.com

Related Content

NVIDIA Launches Clara AI Toolkit for Algorithm Development
News | Artificial Intelligence | March 25, 2019
NVIDIA introduced Clara AI, a toolkit that includes 13 classification and segmentation artificial intelligence (AI)...
Improving Molecular Imaging Using a Deep Learning Approach
News | Nuclear Imaging | March 21, 2019
Generating comprehensive molecular images of organs and tumors in living organisms can be performed at ultra-fast speed...
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Feature | Cardiac Imaging | March 17, 2019 | By Greg Freiherr
Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applica
WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography.

WVU cardiology chief Partho Sengupta, M.D., describes at ACC 2019 how artificial intelligence already helps cardiologists in echocardiography. Photo by Greg Freiherr

Feature | Cardiac Imaging | March 16, 2019 | By Greg Freiherr
Machine learning is already having an enormous impact on cardiology, automatically calculating measurements in echoca
Bay Labs Announces New Data on EchoGPS, AutoEF AI Software at ACC.19
News | Cardiovascular Ultrasound | March 15, 2019
Artificial intelligence (AI) company Bay Labs announced the presentation of two studies assessing performance of the...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Sponsored Content | Videos | Artificial Intelligence | March 13, 2019
At RSNA 2018, iCad showed how its...
Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

Pseudocolor accentuated CT scan image of a liver tumor. Image courtesy of Lucence Diagnostics.

News | Oncology Diagnostics | March 12, 2019
Genomic medicine company Lucence Diagnostics announced a new project to develop artificial intelligence (AI) algorithms...